675
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Regioselective acylation of congeners of 3-amino-1H-pyrazolo[3,4-b]quinolines, their activity on bacterial serine/threonine protein kinases and in vitro antibacterial (including antimycobacterial) activity

, , , &
Pages 1088-1093 | Received 02 Apr 2012, Accepted 24 Jul 2012, Published online: 07 Sep 2012

References

  • Kurosu M, Begari E. Bacterial protein kinase inhibitors. Drug Development Res 2010;71 168–187.
  • Bekker OB, Elizarov SM, Alekseeva MT, Liubimova IK, Danilenko VN. [Ca2+-dependent modulation of antibiotic resistance in Streptomyces lividans 66 and Streptomyces coelicolor A3(2)]. Mikrobiologiia 2008;77:630–638.
  • Petrícková K, Petrícek M. Eukaryotic-type protein kinases in Streptomyces coelicolor: variations on a common theme. Microbiology (Reading, Engl) 2003;149:1609–1621.
  • Danilenko VN, Osolodkin DI, Lakatosh SA, Preobrazhenskaya MN, Shtil AA. Bacterial eukaryotic type serine-threonine protein kinases: from structural biology to targeted anti-infective drug design. Curr Top Med Chem 2011;11:1352–1369.
  • Danilenko VN, Simonov AY, Lakatosh SA, Kubbutat MH, Totzke F, Schächtele C et al. Search for inhibitors of bacterial and human protein kinases among derivatives of diazepines[1,4] annelated with maleimide and indole cycles. J Med Chem 2008;51:7731–7736.
  • Electronic Resources. Available at: http://pubchem.ncbi.nlm.nih.gov/assay. Accessed March 2012.
  • Chioua M, Samadi A, Soriano E, Lozach O, Meijer L, Marco-Contelles J. Synthesis and biological evaluation of 3,6-diamino-1H-pyrazolo[3,4-b]pyridine derivatives as protein kinase inhibitors. Bioorg Med Chem Lett 2009;19:4566–4569.
  • Traxler P, Bold G, Frei J, Lang M, Lydon N, Mett H et al. Use of a pharmacophore model for the design of EGF-R tyrosine kinase inhibitors: 4-(phenylamino)pyrazolo[3,4-d]pyrimidines. J Med Chem 1997;40:3601–3616.
  • Parekh N, Maheria K, Patel P, Rathod M. Study on antibacterial activity for multidrug resistance stain by using phenyl pyrazolones substituted 3-amino-1H-pyrazolon[3,4-b]quinoline derivative in vitro condition. Inter J Pharm Tech Res 2011;3:540–548.
  • Selvi ST, Nadaraj V, Mohan S, Sasi R, Hema M. Solvent free microwave synthesis and evaluation of antimicrobial activity of pyrimido[4,5-b]- and pyrazolo[3,4-b]quinolines. Bioorg Med Chem 2006;14:3896–3903.
  • Amin MAS, Ismail MM, Barakat SES, Abdul-Rahman AAA, Bayomi AH, El-Gamal KMA. Synthesis and antimicrobial activity of some new quinoline and 1H-pyrazolo[3,4-b]quinoline derivatives. Bull Pharm Sci Assiut Univ 2004; 27:237–245.
  • el-Sayed OA, Aboul-Enein HY. Synthesis and antimicrobial activity of novel pyrazolo[3,4-b]quinoline derivatives. Arch Pharm (Weinheim) 2001;334:117–120.
  • Abdel-Rahman AE, Bakhite EA, Abdel-Moneam MI, Mohamed TA. Synthesis and antibacterial activities of some new thieno[2,3-b]quinolines. Phosphorus, Sulfur and Silicon 1992;73:219–227.
  • Afghan A, Baradarani MM, Jouleb JA. Efficient syntheses of 1,3-unsubstituted 1H-pyrazolo[3,4-b]quinolines. ARKIVOC 2009:20–30.
  • Geronikaki A, Druzhilovsky D, Zakharov A, Poroikov V. Computer-aided prediction for medicinal chemistry via the Internet. SAR QSAR Environ Res 2008;19:27–38.
  • Chaczatrian K, Chaczatrian G, Danel A, Tomasik P. The synthesis of 4-aryl-1H-pyrazolo[3,4-b]quinolines by cyclization of 4-arylidenepyrazolin-5-ones with anilines. ARKIVOC 2001:63–69.
  • Elnagdi MH, Abdel-Galil FM, Riad BY, Elgemei GEH. Recent development in chemistry of 3(5)-aminopyrazoles. Heterocycles 1983; 20:2437.
  • Stadlbauer W, Hojas G. Synthesis of 4-azido-3-diazo-3H-3H-pyrazolo[3,4-b]quinoline from 3-amino-4-hydrazino-1H-pyrazolo[3,4-b]quinoline. J Chem Soc Perkin Trans I 2000:3085–3087.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.